rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-8-22
|
pubmed:abstractText |
We investigated whether established graft-vs-host disease (GVHD) could be successfully treated by a second allogeneic bone marrow transplantation (BMT) through elimination of first donor-derived lymphocytes responsible for GVHD.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0301-472X
|
pubmed:author |
pubmed-author:AozasaKatsuyukiK,
pubmed-author:FujiokaTatsuyaT,
pubmed-author:HoshidaYoshihikoY,
pubmed-author:IkegameKazuhiroK,
pubmed-author:InoueTakayukiT,
pubmed-author:KawakamiManabuM,
pubmed-author:KawaseIchiroI,
pubmed-author:MasudaTomokiT,
pubmed-author:OgawaHiroyasuH,
pubmed-author:TaniguchiYukiY,
pubmed-author:YoshiharaSatoshiS
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1216-25
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18599183-Animals,
pubmed-meshheading:18599183-Bone Marrow Transplantation,
pubmed-meshheading:18599183-Female,
pubmed-meshheading:18599183-Graft vs Host Disease,
pubmed-meshheading:18599183-Histocompatibility,
pubmed-meshheading:18599183-Interferon-gamma,
pubmed-meshheading:18599183-Mice,
pubmed-meshheading:18599183-Mice, Inbred C3H,
pubmed-meshheading:18599183-Mice, Inbred DBA,
pubmed-meshheading:18599183-Radiation Chimera,
pubmed-meshheading:18599183-Reoperation,
pubmed-meshheading:18599183-T-Lymphocyte Subsets,
pubmed-meshheading:18599183-T-Lymphocytes, Regulatory,
pubmed-meshheading:18599183-Th1 Cells,
pubmed-meshheading:18599183-Th2 Cells,
pubmed-meshheading:18599183-Tissue Donors,
pubmed-meshheading:18599183-Transplantation, Homologous,
pubmed-meshheading:18599183-Transplantation Conditioning,
pubmed-meshheading:18599183-Transplantation Tolerance,
pubmed-meshheading:18599183-Tumor Necrosis Factor-alpha
|
pubmed:year |
2008
|
pubmed:articleTitle |
Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
|
pubmed:affiliation |
Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|